Senior Housing Growth and a Heavily Shorted Healthcare REIT

American Healthcare REIT, Inc. (AHR) is a self-managed real estate investment trust that owns and invests in a diversified portfolio of healthcare real estate across the United States and select international markets. The company generates revenue through three primary channels:

• Senior Housing Operating Properties (SHOP): The company's largest and most economically sensitive segment. AHR owns the real estate and participates in the operating results of the properties through RIDEA structures, meaning it shares in revenue and bears a share of operating expenses such as labor, food service and utilities. Revenue is driven by occupancy, monthly rent levels and the mix of independent living, assisted living and memory care units.
• Outpatient Medical Properties: Medical office buildings and outpatient facilities leased to health systems, physician groups and other providers under long-term net leases with contractual escalators. This segment provides predictable, inflation-linked cash flow with high tenant retention.
• Integrated Senior Health Campuses: Larger continuing-care-style communities offering a full continuum of care, which combine independent living, assisted living, skilled nursing and rehabilitation on a single campus. These assets benefit from internal referral flows and higher-acuity revenue.

Customers and counterparties. In the SHOP and campus segments, the ultimate customers are residents and their families, paying monthly rates that are frequently supplemented by private long-term care insurance or, for skilled nursing components, government reimbursement programs. In the outpatient medical segment, the customers are health systems and physician practices paying contractual rent.

Scale. AHR operates at meaningful scale, with a market capitalization of $11.1B, 218.00M shares outstanding and a public float of 216.56M shares — a float ratio above 99%, indicating that essentially the entire share base is freely tradable and that there is no large locked-up sponsor stake overhanging the equity. Reported EPS of $0.67 reflects a GAAP earnings base that is depressed relative to the underlying asset value, which is typical for a REIT carrying meaningful depreciation and, in the SHOP segment, operating leverage that has not yet fully normalized post-pandemic.

Near-term (next 4–8 quarters). The primary driver is occupancy recovery and rate growth in the senior housing operating portfolio. Senior housing has been in a supply-constrained environment for several years: construction starts for new senior housing fell sharply following the 2022–2023 cost of capital shock, and the pipeline of new deliveries is now well below the long-run average. With demand from an aging population rising and new supply limited, operators have pricing power. Each 100 basis points of occupancy gain on the operating portfolio flows through to NOI with minimal incremental cost, and rate increases in the mid-single digits compound on top of that. The second near-term driver is margin recapture: labor cost growth has moderated from its peak, and operators that repriced wages upward in 2023–2024 are now annualizing those costs against rising revenue, which expands margins.

Medium-term (3–5 years). Three structural drivers support durable growth. First, demographics: the 80-plus population is growing at a pace that guarantees rising absolute demand for senior housing units regardless of near-term economic conditions. Second, the supply gap: the multi-year hole in construction starts means the industry will face a period of structurally below-trend new supply just as demand accelerates, which is the most favorable demand/supply setup the sector has seen in decades. Third, capital recycling: AHR can fund growth through a combination of retained cash flow, selective dispositions of non-core assets at cap rates below its cost of capital, and joint-venture or downREIT structures that allow it to grow without proportionate balance-sheet leverage. The constraint on medium-term growth is the cost and availability of capital — with the stock at $50.92 and a 0.80 beta, equity issuance is reasonably accretive, but debt markets remain the binding constraint on acquisition pace.

Note: FY2025E–FY2027E are analyst estimates; historical figures are illustrative of the company's reported trajectory and should be reconciled to filed financials.

The trajectory above is driven by three interacting forces. First, revenue growth of roughly 6–8% reflects a blend of occupancy gains and mid-single-digit rate increases in the SHOP segment, partially offset by the contractual, lower-growth escalators in outpatient medical. Second, margin expansion of roughly 70–80 basis points per year comes almost entirely from operating leverage in senior housing as labor cost growth normalizes against rising revenue — this is the single largest swing factor in the model. Third, FFO per share growth of 6.4–9.0% outpaces revenue growth modestly because leverage declines over time, reducing interest expense as a share of NOI.

The reported GAAP EPS of $0.67 is the appropriate anchor for the current period. At $50.92, that implies a P/E near 76x, which underscores why FFO — not EPS — is the correct lens: depreciation on a healthcare real estate portfolio is large and non-economic, and the gap between GAAP EPS and normalized FFO per share of roughly $3.24 is precisely the value that a REIT's cash flow captures and its income statement does not.

Market size. Healthcare real estate in the United States is a large and fragmented asset class. Senior housing alone represents a market with hundreds of billions of dollars of existing asset value, and the institutional ownership share remains well below that of other property types such as office or multifamily — meaning the addressable opportunity for a scaled, public consolidator is still substantial. Outpatient medical is similarly large, driven by the long-running shift of care delivery out of hospitals and into lower-cost ambulatory settings.

Competitive positioning. AHR competes for acquisitions and capital against a set of large, well-capitalized peers. Its differentiation rests on (1) the breadth of its three-segment platform, which lets it underwrite a wider range of deals than a pure-play senior housing or pure-play medical office REIT; (2) its operator relationships in senior housing, which are difficult to replicate and give it access to off-market opportunities; and (3) its scale, with an $11.1B market capitalization that provides access to public debt and equity markets on reasonable terms.

Comparable companies. The most relevant public peers are:

• Welltower (WELL) — the largest and highest-quality healthcare REIT, with a heavy senior housing operating focus and a premium valuation multiple reflecting its scale, balance sheet and operator network.
• Ventas (VTR) — a diversified healthcare REIT with a large senior housing operating portfolio and a substantial research and medical office book, structurally the closest analog to AHR.
• Omega Healthcare Investors (OHI) — a skilled nursing focused triple-net REIT, offering a contrasting, more contractual and higher-yield model with less operating leverage.
• Sabra Health Care REIT (SBRA) — a smaller diversified healthcare REIT with skilled nursing and senior housing exposure, typically trading at a discount to the large-cap peers.

AHR's positioning relative to this group is that of a scaled but still-discounted platform: it carries the operating leverage and growth profile of a Welltower or Ventas-style SHOP model, but with a shorter public track record and a more concentrated operator base, which historically has justified a valuation discount to the two large-cap leaders.

Discounted cash flow. A DCF for a REIT is best constructed on a funds-from-operations or dividend-discount basis rather than on GAAP earnings. Using normalized FFO per share of approximately $3.24 for FY2025E, a cost of equity of roughly 8.5–9.5% (consistent with a 0.80 beta and a REIT-appropriate equity risk premium), and a long-run FFO growth rate of 3.0–3.5% in the terminal period, the implied value lands in a range of roughly $48 to $58 per share. The sensitivity is dominated by the cost of equity: a 100 basis point move in the discount rate shifts fair value by approximately 12–15%, which explains why the stock is so sensitive to rate expectations and why a 4.91% single-day move on no company-specific news is entirely plausible in this name.

Comparable multiples. The table below frames AHR against its closest peers on the metrics REIT investors actually use — price to FFO and EV/EBITDA, alongside the dividend yield and leverage profile.

Peer multiples are indicative sector ranges; AHR multiples are derived from the $50.92 price and the FFO estimates in the Financial Analysis section.

The read-through is that AHR trades at roughly 15.7x forward FFO — a meaningful discount to Ventas at approximately 19x and a very large discount to Welltower at approximately 26x, but at a clear premium to the skilled-nursing-heavy names at roughly 10x. That positioning is defensible: AHR's SHOP-weighted mix deserves a premium to triple-net skilled nursing, but its shorter history, concentrated operator base and higher leverage justify a discount to the two large-cap diversified leaders. Closing even part of the gap to Ventas — say two multiple turns — would imply roughly $58–60 per share, near the top of the 52-week range.

• Operator concentration and RIDEA exposure. A significant share of NOI depends on a limited number of third-party senior housing operators. Labor cost inflation, staffing shortages or the financial distress of a single operator could impair occupancy and force AHR to fund working capital, transition management or sell assets at unfavorable prices. Because the company shares in operating results, cost shocks flow directly to its P&L rather than being absorbed by a tenant.
• Interest rate and refinancing risk. With net debt to EBITDA in the mid-5x range, AHR is meaningfully levered. REIT valuations are highly sensitive to the cost of equity and to long-term rates, and a sustained rise in rates would both compress the multiple the market is willing to pay and increase refinancing costs on maturing debt. This is the most likely driver of further drawdowns toward the $43.33 52-week low.
• Crowded short positioning cuts both ways. The 16.57% of float sold short is a risk in both directions. While it creates squeeze potential on good news, it also means that negative catalysts — a guidance miss, a dividend coverage concern, a credit rating action — can trigger an outsized decline as momentum and systematic strategies add to the position. With 31.81M shares short against 2.95M average volume, liquidity is thin relative to the position.
• Supply and reimbursement policy. The favorable supply backdrop could erode if construction financing loosens and starts accelerate, particularly in high-barrier markets where AHR is concentrated. Separately, changes to Medicare and Medicaid reimbursement — which affect the skilled nursing and higher-acuity components of the integrated campuses — could pressure resident acuity mix and operator economics.
• Execution on external growth. The growth case assumes AHR can recycle capital and acquire assets at spreads above its cost of capital. If cap rates compress further or competition from well-capitalized peers intensifies, acquisition spreads narrow and the FFO growth rate embedded in estimates proves optimistic. Integration risk on larger transactions is also non-trivial for a company with a relatively short public history.